Chara Litou | Senior PBPK Consultant
Certara

BioTechX Europe Day 2 @ 14:55

Predicting First-in-Human PK: From Chemical Structure to PBPK

Could a SMILES string alone help us predict in vivo pharmacokinetics? Equipped with the right PhysChem property predictors and a physiologically-based model of PK, discovery and translational scientists can now look ahead to animal and human ADME from the earliest stage of compound design. Explore the existing tools and what’s on the horizon with Chara Litou, PhD, Senior PBPK Consultant at Certara.

Chara Litou, Senior PBPK Consultant, Certara

×

Chara Litou / Predicting First-in-Human PK: From Chemical Structure to PBPK

Chara Litou, Senior PBPK Consultant,
Certara

Chara is a Senior PBPK Consultant at Certara with extensive experience in PBPK-PD, clinical pharmacology, and translational pharmacokinetics. She is skilled in DMPK and clinical activities, biopredictive in vitro testing, and formulation development. Her work focuses on predicting the in vivo...

CloseMore